articleNature MedicineMar 24, 2003Closed access

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

Cleveland Clinic · Cleveland Eye Clinic · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

652
total citations
FWCI
16.34
Percentile
100%
References
46
Citations per year

Authors

8

Topics & keywords

Keywords
  • Angiogenesis
  • Matrix metalloproteinase
  • Cancer research
  • Choroidal neovascularization
  • Neovascularization
  • Angiogenesis inhibitor
  • Receptor
  • Matrix metalloproteinase inhibitor
No related works found for this paper.

Funding